Pub Date : 2024-07-01Epub Date: 2024-08-01DOI: 10.5144/0256-4947.2024.272
Raghad Alhajaji, Mayada Mohammad Samkari, Mona A Althobaiti, Bashaer Ruddah Al-Ahmadi, Alaa Mohammed Bugis, Amjad Mohammed Bugis, Fatimah Yaseen Sabbagh, Somaya A Althobaiti, Amro S Bukari, Safenaz Meshal Alqurashi, Hana Abdullah Mshrai, Omar Ahmed Abdelwahab
Background: Spontaneous bacterial peritonitis (SBP) represents a critical and potentially lethal condition that typically develops in individuals with liver cirrhosis. This meta-analysis aimed to assess diabetes mellitus (DM) as a risk factor for SBP in liver cirrhotic patients.
Methods: Following PRISMA guidelines, fifteen studies were included, for a total of 76 815 patients. The risk of bias was assessed using the Newcastle-Ottawa scale (NOS). We represented the results as risk ratios (RR) with the corresponding 95% confidence intervals (CI) using RevMan software. Additionally, we pooled the hazard ratios (HR) for developing SBP in patients with DM from the included studies.
Results: The meta-analysis shows a significantly increased risk of SBP in cirrhotic patients with DM (HR: 1.26; 95% CI [1.05-1.51], P=.01; HR: 1.70; 95% CI [1.32-2.18], P<.001).
Conclusions: The study signifies that DM is an independent risk factor for SBP, emphasizing the need for targeted preventive measures in this specific population.
背景:自发性细菌性腹膜炎(SBP自发性细菌性腹膜炎(SBP)是肝硬化患者常见的一种严重且可能致命的疾病。本荟萃分析旨在评估糖尿病(DM)作为肝硬化患者SBP风险因素的情况:按照PRISMA指南,共纳入15项研究,共计76815名患者。采用纽卡斯尔-渥太华量表(NOS)评估了偏倚风险。我们使用RevMan软件将结果显示为风险比(RR)及相应的95%置信区间(CI)。此外,我们还汇总了纳入研究的 DM 患者发生 SBP 的危险比 (HR):荟萃分析表明,肝硬化DM患者罹患SBP的风险显著增加(HR:1.26;95% CI [1.05-1.51],P=.01;HR:1.70;95% CI [1.32-2.18],PC结论:该研究表明,DM 是导致 SBP 的一个独立风险因素,强调了在这一特殊人群中采取有针对性的预防措施的必要性。
{"title":"Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis.","authors":"Raghad Alhajaji, Mayada Mohammad Samkari, Mona A Althobaiti, Bashaer Ruddah Al-Ahmadi, Alaa Mohammed Bugis, Amjad Mohammed Bugis, Fatimah Yaseen Sabbagh, Somaya A Althobaiti, Amro S Bukari, Safenaz Meshal Alqurashi, Hana Abdullah Mshrai, Omar Ahmed Abdelwahab","doi":"10.5144/0256-4947.2024.272","DOIUrl":"10.5144/0256-4947.2024.272","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous bacterial peritonitis (SBP) represents a critical and potentially lethal condition that typically develops in individuals with liver cirrhosis. This meta-analysis aimed to assess diabetes mellitus (DM) as a risk factor for SBP in liver cirrhotic patients.</p><p><strong>Methods: </strong>Following PRISMA guidelines, fifteen studies were included, for a total of 76 815 patients. The risk of bias was assessed using the Newcastle-Ottawa scale (NOS). We represented the results as risk ratios (RR) with the corresponding 95% confidence intervals (CI) using RevMan software. Additionally, we pooled the hazard ratios (HR) for developing SBP in patients with DM from the included studies.</p><p><strong>Results: </strong>The meta-analysis shows a significantly increased risk of SBP in cirrhotic patients with DM (HR: 1.26; 95% CI [1.05-1.51], <i>P</i>=.01; HR: 1.70; 95% CI [1.32-2.18], <i>P</i><.001).</p><p><strong>Conclusions: </strong>The study signifies that DM is an independent risk factor for SBP, emphasizing the need for targeted preventive measures in this specific population.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"272-287"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01Epub Date: 2024-08-01DOI: 10.5144/0256-4947.2024.255
Mohammed Nabil AlAli, Ahmad Zubaidi, Thamer A Bin Traiki, Khayal Alkhayal, Mohammed Sbaih, Saud Khalid Aldeghaither, Farah F Almugrin, Sulaiman Abdullah Alshammari, Mohammed Alswayyed, Maha Abdullah
Background: The appendix is a small organ with no particular known function. Primary appendiceal neoplasms (ANs) are rare. While the prevalence is increasing worldwide over the past two decades, no apparent increase in the prevalence of ANs has been reported in the Arabian Gulf States. Recently, a significant decline in the age at diagnosis of some types of ANs has been reported worldwide, with a female predominance.
Objectives: Evaluate the prevalence and clinicopathological characteristics of ANs within our institution in Saudi Arabia and compare them to limited existing studies from different regions as well as the Arabian Gulf States.
Design: Retrospective cohort.
Setting: Tertiary care center in Riyadh.
Patients and methods: All patients who underwent appendectomy and had the appendix submitted for histopathological evaluation between May 2015 and June 2020 were included to allow for a follow-up of 5 years or more at the time of data collection.
Main outcome measures: Demographics, clinical presentations, surgical interventions, histopathological findings, complications, and recurrence rates.
Sample size: 25 AN patients.
Results: Of 1110 patients, 25 had ANs (13 female and 12 male participants) with a mean (standard deviation) age of 54.6 (14.1) years. Only 40% presented with acute appendicitis, 64% had comorbidities, and less than 50% underwent laparoscopic appendectomy. Histopathologically, 72% were low-grade appendiceal mucinous neoplasms (LAMNs). Complications were minimal grades (Clavien-Dindo classification), with 80% experiencing none. The mean hospital stay was 9.96 days. Local recurrence occurred in 8% of cases, and distant metastasis was documented in one adenocarcinoma case. However, the 5-year overall and disease-free survival rates were 88% and 80%, respectively.
Conclusions: The incidence of ANs is increasing in Saudi Arabia with the higher prevalence of LAMNs. The pathological examination of the resected appendix played a pivotal role in the diagnosis of ANs.
Limitations: Data collected retrospectively, a single institution, and a small population.
{"title":"Appendiceal neoplasms in Saudi Arabia: prevalence and clinicopathological profile.","authors":"Mohammed Nabil AlAli, Ahmad Zubaidi, Thamer A Bin Traiki, Khayal Alkhayal, Mohammed Sbaih, Saud Khalid Aldeghaither, Farah F Almugrin, Sulaiman Abdullah Alshammari, Mohammed Alswayyed, Maha Abdullah","doi":"10.5144/0256-4947.2024.255","DOIUrl":"10.5144/0256-4947.2024.255","url":null,"abstract":"<p><strong>Background: </strong>The appendix is a small organ with no particular known function. Primary appendiceal neoplasms (ANs) are rare. While the prevalence is increasing worldwide over the past two decades, no apparent increase in the prevalence of ANs has been reported in the Arabian Gulf States. Recently, a significant decline in the age at diagnosis of some types of ANs has been reported worldwide, with a female predominance.</p><p><strong>Objectives: </strong>Evaluate the prevalence and clinicopathological characteristics of ANs within our institution in Saudi Arabia and compare them to limited existing studies from different regions as well as the Arabian Gulf States.</p><p><strong>Design: </strong>Retrospective cohort.</p><p><strong>Setting: </strong>Tertiary care center in Riyadh.</p><p><strong>Patients and methods: </strong>All patients who underwent appendectomy and had the appendix submitted for histopathological evaluation between May 2015 and June 2020 were included to allow for a follow-up of 5 years or more at the time of data collection.</p><p><strong>Main outcome measures: </strong>Demographics, clinical presentations, surgical interventions, histopathological findings, complications, and recurrence rates.</p><p><strong>Sample size: </strong>25 AN patients.</p><p><strong>Results: </strong>Of 1110 patients, 25 had ANs (13 female and 12 male participants) with a mean (standard deviation) age of 54.6 (14.1) years. Only 40% presented with acute appendicitis, 64% had comorbidities, and less than 50% underwent laparoscopic appendectomy. Histopathologically, 72% were low-grade appendiceal mucinous neoplasms (LAMNs). Complications were minimal grades (Clavien-Dindo classification), with 80% experiencing none. The mean hospital stay was 9.96 days. Local recurrence occurred in 8% of cases, and distant metastasis was documented in one adenocarcinoma case. However, the 5-year overall and disease-free survival rates were 88% and 80%, respectively.</p><p><strong>Conclusions: </strong>The incidence of ANs is increasing in Saudi Arabia with the higher prevalence of LAMNs. The pathological examination of the resected appendix played a pivotal role in the diagnosis of ANs.</p><p><strong>Limitations: </strong>Data collected retrospectively, a single institution, and a small population.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"255-263"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-07-01Epub Date: 2024-08-01DOI: 10.5144/0256-4947.2024.249
Muath A Alkhunizan, Nouf AlMasoud, Majd Munia Abdulmowla, Zoha Khalid, Mohammed Alshaker, Yaser Abdullah Alendijani
Background: T-score measurement via dual-energy X-ray absorptiometry (DXA) is the gold standard for assessing and classifying the bone mineral density status of patients as normal, osteopenic, or osteoporotic according to the World Health Organization criteria. However, the diagnostic accuracy may be affected by the skeletal site selected for DXA.
Objectives: Estimate the prevalence of femoral and lumbar BMD discordance in a community-based setting in Riyadh, Saudi Arabia.
Design: Cross-sectional.
Setting: Polyclinics at a tertiary care center.
Patients and methods: This study included all patients aged ≥60 years who visited the Department of Family Medicine and underwent DXA screening between 2016 and 2022.
Main outcome measures: Discordance was defined as a difference in BMD status between two skeletal sites. Minor discordance occurs when adjacent sites have different diagnoses; i.e., one site exhibits osteoporosis and the other exhibits osteopenia. In contrast, major discordance occurs when one site exhibits osteoporosis and the other exhibits normal BMD.
Sample size: 1429 older adults.
Results: The study patients had a median age of 66 years (60-99, minimum-maximum). The prevalence of discordance was 41.6%, with major discordance present in 2.2% of patients and minor discordance in 39.4%. The distribution of discordance did not differ significantly among the sociodemographic factors.
Conclusion: Discordance is prevalent among the Saudi geriatric population. During the analysis of DXA results, physicians should account for discordance when diagnosing and ruling out osteoporosis in high-risk patients.
Limitations: All factors influencing discordance were not explored thoroughly; this study mainly focused on older adults. Furthermore, diverse age groups need to be investigated for a more comprehensive understanding of the analyzed factors.
{"title":"Prevalence of discordance between femoral and lumbar bone mineral density among older adults in a community-based setting.","authors":"Muath A Alkhunizan, Nouf AlMasoud, Majd Munia Abdulmowla, Zoha Khalid, Mohammed Alshaker, Yaser Abdullah Alendijani","doi":"10.5144/0256-4947.2024.249","DOIUrl":"10.5144/0256-4947.2024.249","url":null,"abstract":"<p><strong>Background: </strong>T-score measurement via dual-energy X-ray absorptiometry (DXA) is the gold standard for assessing and classifying the bone mineral density status of patients as normal, osteopenic, or osteoporotic according to the World Health Organization criteria. However, the diagnostic accuracy may be affected by the skeletal site selected for DXA.</p><p><strong>Objectives: </strong>Estimate the prevalence of femoral and lumbar BMD discordance in a community-based setting in Riyadh, Saudi Arabia.</p><p><strong>Design: </strong>Cross-sectional.</p><p><strong>Setting: </strong>Polyclinics at a tertiary care center.</p><p><strong>Patients and methods: </strong>This study included all patients aged ≥60 years who visited the Department of Family Medicine and underwent DXA screening between 2016 and 2022.</p><p><strong>Main outcome measures: </strong>Discordance was defined as a difference in BMD status between two skeletal sites. Minor discordance occurs when adjacent sites have different diagnoses; i.e., one site exhibits osteoporosis and the other exhibits osteopenia. In contrast, major discordance occurs when one site exhibits osteoporosis and the other exhibits normal BMD.</p><p><strong>Sample size: </strong>1429 older adults.</p><p><strong>Results: </strong>The study patients had a median age of 66 years (60-99, minimum-maximum). The prevalence of discordance was 41.6%, with major discordance present in 2.2% of patients and minor discordance in 39.4%. The distribution of discordance did not differ significantly among the sociodemographic factors.</p><p><strong>Conclusion: </strong>Discordance is prevalent among the Saudi geriatric population. During the analysis of DXA results, physicians should account for discordance when diagnosing and ruling out osteoporosis in high-risk patients.</p><p><strong>Limitations: </strong>All factors influencing discordance were not explored thoroughly; this study mainly focused on older adults. Furthermore, diverse age groups need to be investigated for a more comprehensive understanding of the analyzed factors.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 4","pages":"249-254"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11316945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.167
Di Wu, Yue Li, Shao-Hua Dong, Yue Gao
Background: Acute respiratory distress syndrome (ARDS), which results in lung injury as a consequence of sepsis and septic shock, is associated with severe systemic inflammation and is responsible for a high worldwide mortality rate.
Objective: Investigate whether corticosteroids could benefit clinical outcomes in adult with ARDS.
Methods: A comprehensive search of electronic databases Ovid MEDLINE, Ovid EMbase, and Cochrane Library from their inception to 7 May 2023 was conducted to identify studies that met the eligibility criteria, including only randomized controlled trials. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the methods of trial sequential analysis.
Main outcome measures: Mortality rates, including including the 14-, 28-, 45-, and 60-day mortality, hospital mortality, and intensive care unit (ICU) mortality.
Sample size: 17 studies with 2508 patients.
Results: Data relating to mortality at 14, 28, 45, and 60 days were not significantly different when treatments with corticosteroids and placebo were compared. In terms of hospital and ICU mortality, the mortality of those who had received corticosteroids was significantly lower than that of those who had not. ARDS patients who received assisted ventilation benefited from corticosteroid therapy, as revealed by the significant difference in outcome days between those who received assisted ventilation and those who did not. Corticosteroid had significantly more days free from mechanical ventilation, ICU-free days, and MODS-free days during the first 28 days, but not more organ support-free days up to day 28.
Conclusion: Although corticosteroid therapy did not reduce mortality rates at different observation periods, it significantly reduced hospital and ICU mortality. Administering corticosteroids to ARDS patients significantly decreased the days of assisted ventilation and time cost consumption. This study confirmed that long-term use of low-dose glucocorticoids may have a positive effect on early ARDS.
Limitation: Risk of bias due to the differences in patient characteristics.
{"title":"Clinical outcomes of corticosteroid administration for acute respiratory distress syndrome in adults based on meta-analyses and trial sequential analysis.","authors":"Di Wu, Yue Li, Shao-Hua Dong, Yue Gao","doi":"10.5144/0256-4947.2024.167","DOIUrl":"10.5144/0256-4947.2024.167","url":null,"abstract":"<p><strong>Background: </strong>Acute respiratory distress syndrome (ARDS), which results in lung injury as a consequence of sepsis and septic shock, is associated with severe systemic inflammation and is responsible for a high worldwide mortality rate.</p><p><strong>Objective: </strong>Investigate whether corticosteroids could benefit clinical outcomes in adult with ARDS.</p><p><strong>Methods: </strong>A comprehensive search of electronic databases Ovid MEDLINE, Ovid EMbase, and Cochrane Library from their inception to 7 May 2023 was conducted to identify studies that met the eligibility criteria, including only randomized controlled trials. The study was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the methods of trial sequential analysis.</p><p><strong>Main outcome measures: </strong>Mortality rates, including including the 14-, 28-, 45-, and 60-day mortality, hospital mortality, and intensive care unit (ICU) mortality.</p><p><strong>Sample size: </strong>17 studies with 2508 patients.</p><p><strong>Results: </strong>Data relating to mortality at 14, 28, 45, and 60 days were not significantly different when treatments with corticosteroids and placebo were compared. In terms of hospital and ICU mortality, the mortality of those who had received corticosteroids was significantly lower than that of those who had not. ARDS patients who received assisted ventilation benefited from corticosteroid therapy, as revealed by the significant difference in outcome days between those who received assisted ventilation and those who did not. Corticosteroid had significantly more days free from mechanical ventilation, ICU-free days, and MODS-free days during the first 28 days, but not more organ support-free days up to day 28.</p><p><strong>Conclusion: </strong>Although corticosteroid therapy did not reduce mortality rates at different observation periods, it significantly reduced hospital and ICU mortality. Administering corticosteroids to ARDS patients significantly decreased the days of assisted ventilation and time cost consumption. This study confirmed that long-term use of low-dose glucocorticoids may have a positive effect on early ARDS.</p><p><strong>Limitation: </strong>Risk of bias due to the differences in patient characteristics.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"167-182"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268472/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.146
Mohamed A A Ibrahim, Khalid M Alhomayani, Usama Gaber, Hashem A Bukhary, Samir A Nematallah, Mostafa M Elgahel
Background: Femoral and tibial fractures may result in delayed union and nonunion, posing significant challenges in orthopedic practice. The Ilizarov technique has emerged as a promising solution for managing these complex cases.
Objectives: Evaluate the radiographic and functional results of Ilizarov fixation in the treatment of nonunion of tibia and femur fractures.
Design: Retrospective.
Settings: Hospitals affiliated with a university hospital.
Patients and methods: Patient demographics, fracture characteristics, and treatment details were analyzed for the period from October 2015 to September 2022 in patients who were treated for nonunion of the tibia and femur using the Ilizarov fixator. Clinical and radiological assessments were performed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria. The study focused on assessing the average duration for union and frame removal, bone results, successful union rates, and functional results using the ASAMI criteria, obtaining data from the existing medical records, spanning various medical facilities treating nonunion fractures.
Sample size: 126 patients.
Results: The average duration for union and frame removal was 8 months, with excellent bone results observed in 60.32% of cases. Out of 126 patients, 118 achieved successful union, while there were 2 failure cases necessitating amputation (1.52%). Functional results revealed excellent outcomes in 39.68% of cases. Complications included pin tract infections, ankle and knee stiffness, and limb shortening. External fixation duration and infection eradication were consistent with previous research, emphasizing the technique's effectiveness.
Conclusions: The Ilizarov technique proved highly effective in managing nonunion tibia and femur fractures, offering favorable outcomes in terms of union, infection control, pain relief, and functional recovery. While excellent bone outcomes do not guarantee optimal function, this method remains a reliable approach for complex cases.
Limitations: Potential biases inherent in retrospective analyses and the need for further randomized controlled trials to comprehensively compare treatment modalities.
{"title":"Radiographic and functional results of Ilizarov fixation in the management of nonunion of tibia and femur fractures: a retrospective case series.","authors":"Mohamed A A Ibrahim, Khalid M Alhomayani, Usama Gaber, Hashem A Bukhary, Samir A Nematallah, Mostafa M Elgahel","doi":"10.5144/0256-4947.2024.146","DOIUrl":"10.5144/0256-4947.2024.146","url":null,"abstract":"<p><strong>Background: </strong>Femoral and tibial fractures may result in delayed union and nonunion, posing significant challenges in orthopedic practice. The Ilizarov technique has emerged as a promising solution for managing these complex cases.</p><p><strong>Objectives: </strong>Evaluate the radiographic and functional results of Ilizarov fixation in the treatment of nonunion of tibia and femur fractures.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Settings: </strong>Hospitals affiliated with a university hospital.</p><p><strong>Patients and methods: </strong>Patient demographics, fracture characteristics, and treatment details were analyzed for the period from October 2015 to September 2022 in patients who were treated for nonunion of the tibia and femur using the Ilizarov fixator. Clinical and radiological assessments were performed using the Association for the Study and Application of Methods of Ilizarov (ASAMI) criteria. The study focused on assessing the average duration for union and frame removal, bone results, successful union rates, and functional results using the ASAMI criteria, obtaining data from the existing medical records, spanning various medical facilities treating nonunion fractures.</p><p><strong>Sample size: </strong>126 patients.</p><p><strong>Results: </strong>The average duration for union and frame removal was 8 months, with excellent bone results observed in 60.32% of cases. Out of 126 patients, 118 achieved successful union, while there were 2 failure cases necessitating amputation (1.52%). Functional results revealed excellent outcomes in 39.68% of cases. Complications included pin tract infections, ankle and knee stiffness, and limb shortening. External fixation duration and infection eradication were consistent with previous research, emphasizing the technique's effectiveness.</p><p><strong>Conclusions: </strong>The Ilizarov technique proved highly effective in managing nonunion tibia and femur fractures, offering favorable outcomes in terms of union, infection control, pain relief, and functional recovery. While excellent bone outcomes do not guarantee optimal function, this method remains a reliable approach for complex cases.</p><p><strong>Limitations: </strong>Potential biases inherent in retrospective analyses and the need for further randomized controlled trials to comprehensively compare treatment modalities.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"146-152"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.135
Reem Alharbi, Osama Almosallam, Sara Albastaki, Asim Almughamsi, Nasser Alsanea
Background: Anastomotic leakage (AL) represents a severe complication after rectal surgery, leading to significant morbidity, mortality, and increased healthcare costs. Despite improvements in surgical methods and perioperative care, the challenge of AL persists.
Objectives: Explore the impact of body mass index (BMI) on the risk of AL following curative treatment for rectal cancer, providing insight into its predictive value.
Design: Retrospective review.
Settings: Data were collected from a single tertiary center, emphasizing the specialized postoperative outcomes in a high-care setting.
Patients and methods: The study population was comprised patients who underwent sphincter-saving surgery combined with neoadjuvant chemoradiation for rectal cancer from 2001 to 2011. Patients with anastomotic stenosis were excluded.
Main outcome measures: The primary outcome investigated was the occurrence of AL post-surgery. Secondary outcomes included the assessment of local cancer recurrence rates within the AL group.
Sample size: 224; 13 excluded.
Results: Of 237 patients who underwent surgery, 13 with anastomotic stenosis were excluded from this study. Of the remaining 224, 15 individuals (6.3%) developed AL. A potential association between higher BMI and increased AL risk was identified. Additionally, the study noted a higher incidence of local rectal cancer recurrence in the group that developed leakage.
Conclusion: The findings suggest BMI as a significant predictive factor for AL after curative rectal cancer treatment. This emphasizes the need for heightened awareness and possible preoperative counseling for obese patients regarding their increased risk of postoperative leakage.
Limitations: The study was retrospective with all the inherit biases of such studies. The sample size was small and this may have introduced a type 2 statistical error.
背景:吻合口漏(AL)是直肠手术后的一种严重并发症,可导致严重的发病率、死亡率和医疗费用的增加。尽管手术方法和围手术期护理有所改进,但 AL 的挑战依然存在:探讨体重指数(BMI)对直肠癌根治性治疗后AL风险的影响,深入了解其预测价值:设计:回顾性研究:数据收集自一家三级医疗中心,强调高护理环境下的专业术后结果:研究对象包括2001年至2011年期间接受括约肌挽救手术联合新辅助化疗治疗直肠癌的患者。不包括吻合口狭窄的患者:主要研究结果:主要研究结果是术后AL的发生率。次要结果包括评估AL组的局部癌症复发率。样本量:224;排除13例:结果:在接受手术的 237 名患者中,有 13 名吻合口狭窄患者被排除在本研究之外。在剩余的 224 名患者中,有 15 人(6.3%)出现了 AL。研究发现,体重指数越高,发生 AL 的风险越高。此外,该研究还注意到,在发生渗漏的人群中,局部直肠癌复发率较高:结论:研究结果表明,体重指数是直肠癌根治性治疗后发生 AL 的重要预测因素。结论:研究结果表明,BMI 是直肠癌根治术后发生 AL 的重要预测因素,这强调了有必要提高肥胖患者对术后渗漏风险增加的认识,并为其提供可能的术前咨询:本研究为回顾性研究,具有此类研究固有的偏倚性。样本量较小,这可能会导致2型统计误差。
{"title":"Role of body mass index in anastomotic leakage after curative treatment for rectal cancer.","authors":"Reem Alharbi, Osama Almosallam, Sara Albastaki, Asim Almughamsi, Nasser Alsanea","doi":"10.5144/0256-4947.2024.135","DOIUrl":"10.5144/0256-4947.2024.135","url":null,"abstract":"<p><strong>Background: </strong>Anastomotic leakage (AL) represents a severe complication after rectal surgery, leading to significant morbidity, mortality, and increased healthcare costs. Despite improvements in surgical methods and perioperative care, the challenge of AL persists.</p><p><strong>Objectives: </strong>Explore the impact of body mass index (BMI) on the risk of AL following curative treatment for rectal cancer, providing insight into its predictive value.</p><p><strong>Design: </strong>Retrospective review.</p><p><strong>Settings: </strong>Data were collected from a single tertiary center, emphasizing the specialized postoperative outcomes in a high-care setting.</p><p><strong>Patients and methods: </strong>The study population was comprised patients who underwent sphincter-saving surgery combined with neoadjuvant chemoradiation for rectal cancer from 2001 to 2011. Patients with anastomotic stenosis were excluded.</p><p><strong>Main outcome measures: </strong>The primary outcome investigated was the occurrence of AL post-surgery. Secondary outcomes included the assessment of local cancer recurrence rates within the AL group.</p><p><strong>Sample size: </strong>224; 13 excluded.</p><p><strong>Results: </strong>Of 237 patients who underwent surgery, 13 with anastomotic stenosis were excluded from this study. Of the remaining 224, 15 individuals (6.3%) developed AL. A potential association between higher BMI and increased AL risk was identified. Additionally, the study noted a higher incidence of local rectal cancer recurrence in the group that developed leakage.</p><p><strong>Conclusion: </strong>The findings suggest BMI as a significant predictive factor for AL after curative rectal cancer treatment. This emphasizes the need for heightened awareness and possible preoperative counseling for obese patients regarding their increased risk of postoperative leakage.</p><p><strong>Limitations: </strong>The study was retrospective with all the inherit biases of such studies. The sample size was small and this may have introduced a type 2 statistical error.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"135-140"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268469/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.161
Elif Kaya Çelik, Fatih Öner, Hatice Güzelküçük Akay
Background: Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular condition characterized by short-term vertigo attacks that significantly affect quality of life.
Objectives: Examine how well a single Epley maneuver worked in an outpatient setting for people with posterior canal benign paroxysmal positional vertigo (PC-BPPV) and whether they needed a second Dix-Hallpike maneuver.
Design: Prospective.
Settings: Otorhinolaryngology department of a tertiary care center.
Patients and methods: Sociodemographic data, body mass index (BMI), and systemic disease history of 75 patients diagnosed with PC-BPPV were recorded, and their relationship with success rates after the modified Epley maneuver was analyzed.
Main outcome measures: Detect cases that could not be repositioned with the diagnostic control Dix-Hallpike test performed 20 minutes after the modified Epley reposition maneuver in the same session in PC-BPPV patients.
Sample size: 75.
Results: Of the 75 patients, 31 were male (41.3%), 44 female (58.6%) with a mean (standard deviation) age of 58.6 (15.9) years age, 54.6% had one or more chronic diseases. BMI was 30 mg/kg2 and above in 31 patients (41.3%). The modified Epley maneuver was successful in 77.3%. No significant relationship was found between additional diseases or BMI in the patient group in whom the maneuver was unsuccessful.
Conclusion: The success rates of repositioning maneuvers in treating patients diagnosed with PC-BPPV are high. However, more than a single maneuver is required in some resistant patients. Second diagnostic and repositioning maneuvers performed in the same session will reduce multiple hospital admissions. While it is helpful to repeat the maneuver in the patient group where it was unsuccessful, other factors causing the failure should be investigated.
Limitations: Lack of follow-up results of patients after 7-10 days.
{"title":"Do single-session Epley maneuvers treat benign paroxysmal positional vertigo?","authors":"Elif Kaya Çelik, Fatih Öner, Hatice Güzelküçük Akay","doi":"10.5144/0256-4947.2024.161","DOIUrl":"10.5144/0256-4947.2024.161","url":null,"abstract":"<p><strong>Background: </strong>Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular condition characterized by short-term vertigo attacks that significantly affect quality of life.</p><p><strong>Objectives: </strong>Examine how well a single Epley maneuver worked in an outpatient setting for people with posterior canal benign paroxysmal positional vertigo (PC-BPPV) and whether they needed a second Dix-Hallpike maneuver.</p><p><strong>Design: </strong>Prospective.</p><p><strong>Settings: </strong>Otorhinolaryngology department of a tertiary care center.</p><p><strong>Patients and methods: </strong>Sociodemographic data, body mass index (BMI), and systemic disease history of 75 patients diagnosed with PC-BPPV were recorded, and their relationship with success rates after the modified Epley maneuver was analyzed.</p><p><strong>Main outcome measures: </strong>Detect cases that could not be repositioned with the diagnostic control Dix-Hallpike test performed 20 minutes after the modified Epley reposition maneuver in the same session in PC-BPPV patients.</p><p><strong>Sample size: </strong>75.</p><p><strong>Results: </strong>Of the 75 patients, 31 were male (41.3%), 44 female (58.6%) with a mean (standard deviation) age of 58.6 (15.9) years age, 54.6% had one or more chronic diseases. BMI was 30 mg/kg<sup>2</sup> and above in 31 patients (41.3%). The modified Epley maneuver was successful in 77.3%. No significant relationship was found between additional diseases or BMI in the patient group in whom the maneuver was unsuccessful.</p><p><strong>Conclusion: </strong>The success rates of repositioning maneuvers in treating patients diagnosed with PC-BPPV are high. However, more than a single maneuver is required in some resistant patients. Second diagnostic and repositioning maneuvers performed in the same session will reduce multiple hospital admissions. While it is helpful to repeat the maneuver in the patient group where it was unsuccessful, other factors causing the failure should be investigated.</p><p><strong>Limitations: </strong>Lack of follow-up results of patients after 7-10 days.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"161-166"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.141
Riza Dur, Aysel Nalcakan, Okan Aytekin, Derya Akdag Cirik, Basak Yaniktepe, Orhan Gelisen
Background: Medical treatment, expectant approaches, and surgical treatment options are available in the treatment of ectopic pregnancy. Regardless of the treatment, in addition to its effectiveness, the main concern is to limit the risk of relapse and preserve fertility.
Objectives: Determine the impact of medical or surgical treatment for ectopic pregnancy on future fertility.
Design: Retrospective.
Setting: Department of obstrtrics and gynecolgy at Ankara Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.
Patients and methods: Patients who were treated for ectopic pregnancy between June 2016 and November 2019 were allocated into two groups. Expectant approach or medical treatment by methotrexate constituted the conservative treatment group while salpingectomy by laparoscopy indicated the surgical treatment group.
Main outcome measures: Fertility rates within two years following treatment were evaluated according to treatment options.
Sample size: 202 patients.
Results: Of the 202 patients, 128 had medical treatment and 74 patients had surgical treatment for ectopic pregnancy. Of 272 diagnosed with ectopic pregnancy, 70 were excluded for various reasons. Parity and unemployment rate was significantly higher in the surgical treatment (P=.006 and P=.12, respectively). Moreover, ectopic mass size and serum β-hCG levels were significantly higher in the surgical treatment group (P<.001 and P<.001, respectively). There were no significant differences between the conservative and surgical treatment groups in time to pregnancy (17.0 months vs 19.0 months, P=.255). Similarly, there was no significant difference between the conservative and surgical treatment groups with respect to history of infertility (P=.12). There were no significant differences between the conservative and surgical treatment groups in terms of live birth (51.6% vs 44.6%) and ectopic pregnancy (2.3% vs 1.4%) (P=.72 for both). There was no significant difference between the conservative and surgical treatment groups with respect to infertility rate (35.9% vs 41.9%, P=.72) and admittance to the IVF program (3.9% vs 6.8%, P=.39) following ectopic pregnancy treatment.
Conclusions: Reproductive outcomes did not differ significantly in women undergoing expectant management, medical treatment, and surgery for ectopic pregnancy. This finding suggests that clinicians should not hesitate to act in favor of surgical treatment for ectopic pregnancy even if there were concerns for future fertility.
{"title":"The effects of conservative and surgical approaches in tubal ectopic pregnancy on fertility.","authors":"Riza Dur, Aysel Nalcakan, Okan Aytekin, Derya Akdag Cirik, Basak Yaniktepe, Orhan Gelisen","doi":"10.5144/0256-4947.2024.141","DOIUrl":"10.5144/0256-4947.2024.141","url":null,"abstract":"<p><strong>Background: </strong>Medical treatment, expectant approaches, and surgical treatment options are available in the treatment of ectopic pregnancy. Regardless of the treatment, in addition to its effectiveness, the main concern is to limit the risk of relapse and preserve fertility.</p><p><strong>Objectives: </strong>Determine the impact of medical or surgical treatment for ectopic pregnancy on future fertility.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Setting: </strong>Department of obstrtrics and gynecolgy at Ankara Etlik Zübeyde Hanım Women's Health Training and Research Hospital, Ankara, Turkey.</p><p><strong>Patients and methods: </strong>Patients who were treated for ectopic pregnancy between June 2016 and November 2019 were allocated into two groups. Expectant approach or medical treatment by methotrexate constituted the conservative treatment group while salpingectomy by laparoscopy indicated the surgical treatment group.</p><p><strong>Main outcome measures: </strong>Fertility rates within two years following treatment were evaluated according to treatment options.</p><p><strong>Sample size: </strong>202 patients.</p><p><strong>Results: </strong>Of the 202 patients, 128 had medical treatment and 74 patients had surgical treatment for ectopic pregnancy. Of 272 diagnosed with ectopic pregnancy, 70 were excluded for various reasons. Parity and unemployment rate was significantly higher in the surgical treatment (<i>P</i>=.006 and <i>P</i>=.12, respectively). Moreover, ectopic mass size and serum β-hCG levels were significantly higher in the surgical treatment group (<i>P</i><.001 and <i>P</i><.001, respectively). There were no significant differences between the conservative and surgical treatment groups in time to pregnancy (17.0 months vs 19.0 months, <i>P</i>=.255). Similarly, there was no significant difference between the conservative and surgical treatment groups with respect to history of infertility (<i>P</i>=.12). There were no significant differences between the conservative and surgical treatment groups in terms of live birth (51.6% vs 44.6%) and ectopic pregnancy (2.3% vs 1.4%) (<i>P</i>=.72 for both). There was no significant difference between the conservative and surgical treatment groups with respect to infertility rate (35.9% vs 41.9%, <i>P</i>=.72) and admittance to the IVF program (3.9% vs 6.8%, <i>P</i>=.39) following ectopic pregnancy treatment.</p><p><strong>Conclusions: </strong>Reproductive outcomes did not differ significantly in women undergoing expectant management, medical treatment, and surgery for ectopic pregnancy. This finding suggests that clinicians should not hesitate to act in favor of surgical treatment for ectopic pregnancy even if there were concerns for future fertility.</p><p><strong>Limitations: </strong>Retrospective study.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"141-145"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268477/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.153
Abdulrahman Aldakheel, Mohammed Aldehaim, Mohammed Saleh Alwhaid, Renda Alhabib, Muhammad Suhail Anwar, Balqees Alzayed, Khurram Shehzad, Hazem Ghebeh, Nasser Al-Rajhi
Background: Nasopharyngeal carcinoma (NPC) is a rare disease worldwide; To the best of our knowledge, there is no established standard of care specifically tailored for the adolescent population. The majority of existing research relies on retrospective data analysis.
Objective: Evaluate clinical features, treatment results, prognostic factors and late toxicities of locally advanced NPC patients treated with tomotherapy.
Design: Retrospective.
Settings: Tertiary care hospital.
Patients and methods: Between January 2007 and January 2020, we treated patients with NPC, aged between 14 and 21 years, with concomitant chemoradiotherapy using tomotherapy at our institution. We prospectively collected details of clinical characteristics, treatment modalities, outcomes and prognostic factors of these patients and then analysed them retrospectively.
Main outcome measures: 3-5 years overall survival (OS), 3-5 years locoregional control rate, 3-5 years disease-free survival (DFS), prognostic factors.
Sample size: 51 patients.
Results: There were 26 male and 25 female patients included in our study. The mean age was 16.5 years, 5 (9.8%) patients with stage III, and 46 (90.2%) with stage IVa according to the American Joint Committee on Cancer, 8th edition staging system. Most patients (98%) received two or more cycles of induction chemotherapy. All patients received concomitant chemoradiotherapy. The median total dose of radiotherapy delivered was 6600 cGy (range 4800-7000). With a median follow-up of 73 months (range 9-168 months), a 5-year locoregional control rate, 5-year OS and 5-year DFS rates were 100%, 86.8% and 71.7%, respectively. Five years later, disease control was 71.7%. Ten (19.6%) patients had disease recurrence in the form of distant metastases during the follow up.
Conclusions: Helical tomotherapy has an excellent late toxicity profile without compromising clinical outcome for patients with NPC. Radiotherapy remains the mainstay of treatment of nasopharyngeal carcinoma to achieve remarkable local control rates.
Limitations: Single institution experience, small number of patients, and retrospective design.
{"title":"Locally advanced nasopharyngeal carcinoma in adolescents treated with tomotherapy: Experience at King Faisal Specialist Hospital and Research Centre.","authors":"Abdulrahman Aldakheel, Mohammed Aldehaim, Mohammed Saleh Alwhaid, Renda Alhabib, Muhammad Suhail Anwar, Balqees Alzayed, Khurram Shehzad, Hazem Ghebeh, Nasser Al-Rajhi","doi":"10.5144/0256-4947.2024.153","DOIUrl":"10.5144/0256-4947.2024.153","url":null,"abstract":"<p><strong>Background: </strong>Nasopharyngeal carcinoma (NPC) is a rare disease worldwide; To the best of our knowledge, there is no established standard of care specifically tailored for the adolescent population. The majority of existing research relies on retrospective data analysis.</p><p><strong>Objective: </strong>Evaluate clinical features, treatment results, prognostic factors and late toxicities of locally advanced NPC patients treated with tomotherapy.</p><p><strong>Design: </strong>Retrospective.</p><p><strong>Settings: </strong>Tertiary care hospital.</p><p><strong>Patients and methods: </strong>Between January 2007 and January 2020, we treated patients with NPC, aged between 14 and 21 years, with concomitant chemoradiotherapy using tomotherapy at our institution. We prospectively collected details of clinical characteristics, treatment modalities, outcomes and prognostic factors of these patients and then analysed them retrospectively.</p><p><strong>Main outcome measures: </strong>3-5 years overall survival (OS), 3-5 years locoregional control rate, 3-5 years disease-free survival (DFS), prognostic factors.</p><p><strong>Sample size: </strong>51 patients.</p><p><strong>Results: </strong>There were 26 male and 25 female patients included in our study. The mean age was 16.5 years, 5 (9.8%) patients with stage III, and 46 (90.2%) with stage IVa according to the American Joint Committee on Cancer, 8th edition staging system. Most patients (98%) received two or more cycles of induction chemotherapy. All patients received concomitant chemoradiotherapy. The median total dose of radiotherapy delivered was 6600 cGy (range 4800-7000). With a median follow-up of 73 months (range 9-168 months), a 5-year locoregional control rate, 5-year OS and 5-year DFS rates were 100%, 86.8% and 71.7%, respectively. Five years later, disease control was 71.7%. Ten (19.6%) patients had disease recurrence in the form of distant metastases during the follow up.</p><p><strong>Conclusions: </strong>Helical tomotherapy has an excellent late toxicity profile without compromising clinical outcome for patients with NPC. Radiotherapy remains the mainstay of treatment of nasopharyngeal carcinoma to achieve remarkable local control rates.</p><p><strong>Limitations: </strong>Single institution experience, small number of patients, and retrospective design.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"153-160"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-05-01Epub Date: 2024-06-06DOI: 10.5144/0256-4947.2024.183
Nan Guo, Haokun Tian, Tiangang Song, Yu Peng
Background: The current understanding of the correlation between TLR4 gene (toll-like receptor 4) rs4986790 and rs4986791 polymorphisms and asthma susceptibility is inconclusive, with studies and populations yielding conflicting results.
Objectives: Evaluate this relationship using meta-analysis and trial sequential analysis (TSA).
Patients and methods: Databases were systematically queried for relevant articles from the establishment of the database to 19 June 2023 adhering to predefined inclusion and exclusion criteria. Two authors independently conducted screening, data extraction, and quality evaluation. Meta-analysis and TSA were carried out using RevMan 5.4, StataMP 17.0, and TSA 0.9.5.10 Beta, with α=0.05. Subgroup analyses were conducted based on racial demographics. A sensitivity analysis was conducted employing a one-by-one exclusion method. Publication bias was assessed using the Begg and Egger tests.
Main outcome measures: Association of asthma susceptibility with TLR4 gene rs4986790 and rs4986791 polymorphisms.
Sample size: 23 articles included 22 studies on the rs4986790 polymorphism and 11 studies on the rs4986791 polymorphism on the TLR4 gene.
Results: Out of 692 studies screened, 23 met the inclusion criteria. While the overall meta-analysis showed no significant association between the TLR4 rs4986790 polymorphism and asthma susceptibility, subgroup analysis revealed a significant link in the Caucasian population. A significant association was noted in the meta-analysis, particularly among Asian populations, on the rs4986791 polymorphism. The sensitivity analysis indicated that the meta-analysis results were relatively stable. Publication bias analysis revealed minimal influence from publication bias. However, TSA was underscored by the necessity for additional original studies to further validate specific outcomes.
Conclusions: Our study underscores the ethnicity-specific impact on the relationship between TLR4 polymorphisms and asthma susceptibility. While the overall findings for rs4986790 were not significant, the association with the Caucasian population merits further investigation. Furthermore, rs4986791 demonstrated a significant correlation with asthma susceptibility, specifically among Asian populations.
Limitations: Our study predominantly examined the rs4986790 and rs4986791 polymorphisms, overlooking the potential influence of other genetic variants within TLR4.
{"title":"Association of TLR4 gene rs4986790 and rs4986791 polymorphisms with asthma susceptibility: meta-analysis and trial sequential analysis.","authors":"Nan Guo, Haokun Tian, Tiangang Song, Yu Peng","doi":"10.5144/0256-4947.2024.183","DOIUrl":"10.5144/0256-4947.2024.183","url":null,"abstract":"<p><strong>Background: </strong>The current understanding of the correlation between TLR4 gene (toll-like receptor 4) rs4986790 and rs4986791 polymorphisms and asthma susceptibility is inconclusive, with studies and populations yielding conflicting results.</p><p><strong>Objectives: </strong>Evaluate this relationship using meta-analysis and trial sequential analysis (TSA).</p><p><strong>Patients and methods: </strong>Databases were systematically queried for relevant articles from the establishment of the database to 19 June 2023 adhering to predefined inclusion and exclusion criteria. Two authors independently conducted screening, data extraction, and quality evaluation. Meta-analysis and TSA were carried out using RevMan 5.4, StataMP 17.0, and TSA 0.9.5.10 Beta, with α=0.05. Subgroup analyses were conducted based on racial demographics. A sensitivity analysis was conducted employing a one-by-one exclusion method. Publication bias was assessed using the Begg and Egger tests.</p><p><strong>Main outcome measures: </strong>Association of asthma susceptibility with TLR4 gene rs4986790 and rs4986791 polymorphisms.</p><p><strong>Sample size: </strong>23 articles included 22 studies on the rs4986790 polymorphism and 11 studies on the rs4986791 polymorphism on the TLR4 gene.</p><p><strong>Results: </strong>Out of 692 studies screened, 23 met the inclusion criteria. While the overall meta-analysis showed no significant association between the TLR4 rs4986790 polymorphism and asthma susceptibility, subgroup analysis revealed a significant link in the Caucasian population. A significant association was noted in the meta-analysis, particularly among Asian populations, on the rs4986791 polymorphism. The sensitivity analysis indicated that the meta-analysis results were relatively stable. Publication bias analysis revealed minimal influence from publication bias. However, TSA was underscored by the necessity for additional original studies to further validate specific outcomes.</p><p><strong>Conclusions: </strong>Our study underscores the ethnicity-specific impact on the relationship between TLR4 polymorphisms and asthma susceptibility. While the overall findings for rs4986790 were not significant, the association with the Caucasian population merits further investigation. Furthermore, rs4986791 demonstrated a significant correlation with asthma susceptibility, specifically among Asian populations.</p><p><strong>Limitations: </strong>Our study predominantly examined the rs4986790 and rs4986791 polymorphisms, overlooking the potential influence of other genetic variants within TLR4.</p>","PeriodicalId":93875,"journal":{"name":"Annals of Saudi medicine","volume":"44 3","pages":"183-194"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11268470/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}